# Anthony J. Windebank, M.D., Clinical Investigator – FDA Inspection, Sep 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/anthony-j-windebank-md-clinical-investigator/7792e774-c214-42f5-8c76-95585057b14e
Source feed: FDA_Inspections

> FDA inspection 1102472 of Anthony J. Windebank, M.D., Clinical Investigator, September 19, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102472
- Company Name: Anthony J. Windebank, M.D., Clinical Investigator
- Inspection Date: 2019-09-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sharon-l-matson/1d2e6d91-1d00-455d-a2e6-a73b1c6b82cc)

Company: https://www.keypedia.com/companies/anthony-j-windebank-md-clinical-investigator/cc7cd312-c99b-49ae-a603-105653a303fa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d